Kyle Faget Authors Article on ‘Compliance Considerations for Entities Providing Hybrid Clinical Trial Services’
April 28, 2022
Journal of Health Care Compliance
Foley & Lardner LLP Partner Kyle Faget authored the article, “Compliance Considerations for Entities Providing Hybrid Clinical Trial Services,” for the March-April 2022 issue of the Journal of Health Care Compliance. In the article, she discusses how clinical trials are leveraging telehealth, the new business model of hybrid clinical trial services, and compliance considerations that should be addressed to enter the market safely.
People
Related News
December 29, 2025
In the News
Matt Kiel Featured by Los Angeles Business Journal – 'Keep pressing forward and doing your best'
Foley & Lardner LLP senior counsel Matt Kiel is featured by Los Angeles Business Journal for his career journey in the article, “Matt Kiel's Steady Climb.”
December 26, 2025
In the News
Louis Lehot Shares 2026 M&A Outlook on Financing, Exits, and Key Trends
Foley & Lardner LLP partner Louis Lehot was featured in the Mergers & Acquisitions' week-long series, “The 2026 M&A Outlook.”
December 24, 2025
In the News
Kyle Faget on HHS Gender-Affirming Care Declaration – Impact is 'Enormous'
Foley & Lardner LLP partner Kyle Faget commented on the recent Department of Health and Human Services declaration rejecting gender-affirming care in the STAT News article, “Nineteen states, D.C. sue HHS over gender-affirming care crackdown."